Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort

Matthew B. Clements, Emily A. Vertosick, Lourdes Guerrios-Rivera, Amanda M. De Hoedt, Javier Hernandez, Michael A Liss, Robin J. Leach, Stephen J. Freedland, Alexander Haese, Francesco Montorsi, Stephen A. Boorjian, Cedric Poyet, Donna P Ankerst, Andrew J. Vickers

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: The risk of high-grade prostate cancer, given a family history of cancer, has been described in the general population, but not among men selected for prostate biopsy in an international cohort. Objective: To estimate the risk of high-grade prostate cancer on biopsy based on a family history of cancer. Design, setting, and participants: This is a multicenter study of men undergoing prostate biopsy from 2006 to 2019, including 12 sites in North America and Europe. All sites recorded first-degree prostate cancer family histories; four included more detailed data on the number of affected relatives, second-degree relatives with prostate cancer, and breast cancer family history. Outcomes measurements and statistical analysis: Multivariable logistic regressions evaluated odds of high-grade (Gleason grade group ≥2) prostate cancer. Separate models were fit for family history definitions, including first- and second-degree prostate cancer and breast cancer family histories. Results and limitations: A first-degree prostate cancer family history was available for 15 799 men, with a more detailed family history for 4617 (median age 65 yr, both cohorts). Adjusted odds of high-grade prostate cancer were 1.77 times greater (95% confidence interval [CI] 1.57−2.00, p < 0.001, risk ratio [RR] = 1.40) with first-degree prostate cancer, 1.38 (95% CI 1.07−1.77, p = 0.011, RR = 1.22) for second-degree prostate cancer, and 1.30 (95% CI 1.01−1.67, p = 0.040, RR = 1.18) for first-degree breast cancer family histories. Interaction terms revealed that the effect of a family history did not differ based on prostate-specific antigen but differed based on age. This study is limited by missing data on race and prior negative biopsy. Conclusions: Men with indications for biopsy and a family history of prostate or breast cancer can be counseled that they have a moderately increased risk of high-grade prostate cancer, independent of other risk factors. Patient summary: In a large international series of men selected for prostate biopsy, finding a high-grade prostate cancer was more likely in men with a family history of prostate or breast cancer.

Original languageEnglish (US)
Pages (from-to)163-169
Number of pages7
JournalEuropean Urology
Volume82
Issue number2
DOIs
StatePublished - Aug 2022

Keywords

  • Biopsy
  • Breast cancer
  • Diagnosis
  • Family history
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort'. Together they form a unique fingerprint.

Cite this